Skip to main content

Table 1 Characteristics of population

From: Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study

 

Dose Level

 

300 mg/m2

400 mg/m2

500 mg/m2

No. of patients

3

3

23

Age (years)

   

   Mean

68

50

58

   Range

63–75

42–62

40–75

Sex

   

   Male

3

1

17

   Female

0

2

6

Karnofsky Performance Status

   

   100%

2

1

9

   90%

0

1

7

   80%

1

1

7

Clinical stage

   

   cT2cN3

0

0

2

   cT3cN2

2

0

1

   cT3cN3

0

0

6

   cT4 cN0

0

0

6

   cT4 cN2

0

2

5

   cT4 cN3

1

1

3

Histology

   

   Adenocarcinoma

0

2

6

   Squamous Carcinoma

1

1

15

   Adenosquamous Carcinoma

1

0

1

   Large-Cell Carcinoma

1

0

1